amonafide
information and resources from the National Cancer Institute
NCI Thesaurus | amonafide
An imide derivative of naphthalic acid. Amonafide intercalates into DNA and inhibits topoisomerase II, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis. NCI Thesaurus | amonafide
An imide derivative of naphthalic acid. Amonafide intercalates into DNA and inhibits topoisomerase II, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis.
|
|
|
|
news articles
Xanthus Initiates a Phase 2 Study Of Xanafide in Combination with ... Oct 20, 2005
Yahoo! News (press release) 20 /PRNewswire/ -- Xanthus Life Sciences today announced the commencement of a Phase 2 study of Xanafide(TM) (amonafide malate) in combination with cytosine ...
Xanthus Initiates a Phase 2 Study Of Xanafide in Combination with ... Oct 20, 2005
PharmaLive.com (press release), Mass., October 20, 2005 /PRNewswire/ -- Xanthus Life Sciences today announced the commencement of a Phase 2 study of Xanafide(TM) (amonafide malate) in ...
ChemGenex to Present at Rodman & Renshaw Techvest 7th Annual ... Nov 7, 2005
PR Newswire (press release), ...recent advances in the company's Phase 2 clinical programs, Ceflatonin(R) (HHT) for the treatment of leukemias and Quinamed(R) (amonafide dihydrochloride) for ...
ChemGenex to Present at Rodman & Renshaw Techvest 7th Annual ... Nov 7, 2005
Yahoo! News (press release) ...on recent advances in the company's Phase 2 clinical programs, Ceflatonin® (HHT) for the treatment of leukemias and Quinamed® (amonafide dihydrochloride) for ...
|
|
